. (CERF)
- - (-)
Market Cap: -
As of 12/31/69 07:00 PM EST. Market closed.
. (CERF)
-
- (-)
Market Cap: -
As of 12/31/69 07:00 PM EST. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
-
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| COLES N ANTHONY | Director | Apr 01, 2024 | Option Exercise | $3.50 | 50,000 | 175,000 | 65,638 | Apr 03, 2024, 04:15 PM |
| COLES N ANTHONY | Director | Apr 01, 2024 | Sale | $42.33 | 50,000 | 2,116,640 | 15,638 | Apr 03, 2024, 04:15 PM |
| COLES N ANTHONY | Director | Mar 04, 2024 | Option Exercise | $3.50 | 50,000 | 175,000 | 65,638 | Mar 06, 2024, 04:15 PM |
| COLES N ANTHONY | Director | Mar 04, 2024 | Sale | $41.01 | 50,000 | 2,050,550 | 15,638 | Mar 06, 2024, 04:15 PM |
| COLES N ANTHONY | Director | Feb 29, 2024 | Option Exercise | $3.50 | 50,000 | 175,000 | 65,638 | Mar 04, 2024, 05:49 PM |
| COLES N ANTHONY | Director | Feb 29, 2024 | Sale | $41.16 | 50,000 | 2,057,890 | 15,638 | Mar 04, 2024, 05:49 PM |
| Renger John | Chief Scientific Officer | Feb 07, 2024 | Sale | $41.54 | 2,161 | 89,777 | 6,370 | Feb 08, 2024, 07:19 PM |
| COLES N ANTHONY | Director | Feb 07, 2024 | Sale | $41.54 | 2,506 | 104,110 | 15,638 | Feb 08, 2024, 07:14 PM |
| Tregoning Kathleen | See Remarks | Dec 26, 2023 | Option Exercise | $10.05 | 3,150 | 31,658 | 10,666 | Dec 28, 2023, 04:15 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 26, 2023 | Option Exercise | $3.50 | 10,000 | 35,000 | 24,673 | Dec 28, 2023, 04:15 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 26, 2023 | Sale | $42.47 | 10,000 | 424,700 | 14,673 | Dec 28, 2023, 04:15 PM |
| DiPietro Kenneth | Chief Human Resources Officer | Dec 22, 2023 | Option Exercise | $3.50 | 8,000 | 28,000 | 32,663 | Dec 27, 2023, 04:15 PM |
| DiPietro Kenneth | Chief Human Resources Officer | Dec 22, 2023 | Sale | $41.45 | 8,000 | 331,608 | 24,663 | Dec 27, 2023, 04:15 PM |
| Bodenrader Mark | See Remarks | Dec 20, 2023 | Sale | $41.42 | 7,889 | 326,788 | 17,724 | Dec 21, 2023, 08:27 PM |
| DiPietro Kenneth | Chief Human Resources Officer | Dec 20, 2023 | Sale | $41.42 | 6,256 | 259,144 | 24,663 | Dec 21, 2023, 08:24 PM |
| Akamine Scott | Chief Legal Officer | Dec 20, 2023 | Sale | $41.42 | 7,072 | 292,945 | 7,237 | Dec 21, 2023, 08:21 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 20, 2023 | Sale | $41.42 | 10,152 | 420,528 | 14,673 | Dec 21, 2023, 08:14 PM |
| ALTSCHULLER Susan | Chief Financial Officer | Dec 20, 2023 | Sale | $41.42 | 13,808 | 571,972 | 16,913 | Dec 21, 2023, 08:12 PM |
| Tregoning Kathleen | See Remarks | Dec 20, 2023 | Sale | $41.42 | 6,288 | 260,469 | 7,516 | Dec 21, 2023, 08:10 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 15, 2023 | Option Exercise | $9.88 | 7,500 | 74,100 | 7,500 | Dec 19, 2023, 04:15 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 15, 2023 | Sale | $41.39 | 7,500 | 310,393 | 0 | Dec 19, 2023, 04:15 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 07, 2023 | Option Exercise | $3.50 | 10,000 | 35,000 | 10,000 | Dec 11, 2023, 04:17 PM |
| Sanchez Ramiro | Chief Medical Officer | Dec 07, 2023 | Sale | $41.37 | 10,000 | 413,700 | 0 | Dec 11, 2023, 04:17 PM |
| Akamine Scott | Chief Legal Officer | Dec 07, 2023 | Option Exercise | $13.17 | 10,000 | 131,700 | 10,513 | Dec 07, 2023, 07:45 PM |
| Akamine Scott | Chief Legal Officer | Dec 05, 2023 | Option Exercise | $13.17 | 7,500 | 98,775 | 8,013 | Dec 07, 2023, 07:45 PM |
| Akamine Scott | Chief Legal Officer | Dec 07, 2023 | Sale | $41.37 | 10,000 | 413,700 | 513 | Dec 07, 2023, 07:45 PM |
| Akamine Scott | Chief Legal Officer | Dec 05, 2023 | Sale | $35.00 | 7,500 | 262,500 | 513 | Dec 07, 2023, 07:45 PM |
| COLES N ANTHONY | Director | Nov 14, 2023 | Option Exercise | $3.50 | 22,824 | 79,884 | 25,528 | Nov 16, 2023, 04:15 PM |
| COLES N ANTHONY | Director | Nov 14, 2023 | Sale | $25.13 | 22,824 | 573,455 | 2,704 | Nov 16, 2023, 04:15 PM |
| COLES N ANTHONY | Director | Nov 08, 2023 | Option Exercise | $3.50 | 100 | 350 | 2,804 | Nov 09, 2023, 05:03 PM |
| COLES N ANTHONY | Director | Nov 07, 2023 | Option Exercise | $3.50 | 27,076 | 94,766 | 29,780 | Nov 09, 2023, 05:03 PM |
| COLES N ANTHONY | Director | Nov 08, 2023 | Sale | $25.16 | 100 | 2,516 | 2,704 | Nov 09, 2023, 05:03 PM |
| COLES N ANTHONY | Director | Nov 07, 2023 | Sale | $25.02 | 27,076 | 677,555 | 2,704 | Nov 09, 2023, 05:03 PM |
| COLES N ANTHONY | Director | Nov 02, 2023 | Option Exercise | $3.50 | 38,599 | 135,097 | 41,303 | Nov 06, 2023, 05:12 PM |
| COLES N ANTHONY | Director | Nov 03, 2023 | Option Exercise | $3.50 | 61,401 | 214,904 | 64,105 | Nov 06, 2023, 05:12 PM |
| COLES N ANTHONY | Director | Nov 02, 2023 | Sale | $25.19 | 38,599 | 972,239 | 2,704 | Nov 06, 2023, 05:12 PM |
| COLES N ANTHONY | Director | Nov 03, 2023 | Sale | $25.43 | 61,401 | 1,561,458 | 2,704 | Nov 06, 2023, 05:12 PM |
| PATRICK DEVAL L | Director | Nov 01, 2023 | Option Exercise | $12.62 | 30,130 | 380,241 | 33,412 | Nov 03, 2023, 04:15 PM |
| PATRICK DEVAL L | Director | Nov 01, 2023 | Sale | $25.00 | 30,130 | 753,250 | 3,282 | Nov 03, 2023, 04:15 PM |
| Gordon Christopher R | Director | Oct 16, 2023 | Buy | $22.81 | 5,480,052 | 124,999,983 | 65,679,781 | Oct 18, 2023, 04:30 PM |
| Koppel Adam | Director | Oct 16, 2023 | Buy | $22.81 | 5,480,052 | 124,999,983 | 65,679,781 | Oct 18, 2023, 04:30 PM |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | Oct 16, 2023 | Buy | $22.81 | 5,480,052 | 124,999,983 | 65,679,781 | Oct 18, 2023, 04:30 PM |
| PERCEPTIVE ADVISORS LLC | Director | Oct 16, 2023 | Buy | $22.81 | 876,808 | 19,999,990 | 10,794,876 | Oct 17, 2023, 04:53 PM |
| COLES N ANTHONY | Director | Sep 07, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Sep 08, 2023, 04:35 PM |
| COLES N ANTHONY | Director | Sep 07, 2023 | Sale | $24.07 | 50,000 | 1,203,415 | 2,704 | Sep 08, 2023, 04:35 PM |
| Renaud Ronald C JR | President & CEO | Aug 03, 2023 | Buy | $23.96 | 83,857 | 2,008,811 | 83,857 | Aug 07, 2023, 05:13 PM |
| Burgess Paul D. | See Remarks | Aug 04, 2023 | Buy | $22.93 | 21,880 | 501,794 | 21,880 | Aug 07, 2023, 05:11 PM |
| COLES N ANTHONY | Director | Jul 11, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Jul 13, 2023, 05:41 PM |
| COLES N ANTHONY | Director | Jul 11, 2023 | Sale | $30.03 | 50,000 | 1,501,340 | 2,704 | Jul 13, 2023, 05:41 PM |
| DEKKERS MARIJN E | Director | Jun 15, 2023 | Sale | $34.43 | 200,000 | 6,886,000 | 402,326 | Jun 20, 2023, 04:56 PM |
| COLES N ANTHONY | CEO and Chairperson | Jun 01, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Jun 05, 2023, 08:12 PM |
| COLES N ANTHONY | CEO and Chairperson | Jun 01, 2023 | Sale | $32.60 | 50,000 | 1,630,070 | 2,704 | Jun 05, 2023, 08:12 PM |
| Bodenrader Mark | See Remarks | Jun 02, 2023 | Sale | $32.95 | 1,895 | 62,440 | 5,522 | Jun 05, 2023, 08:07 PM |
| COLES N ANTHONY | CEO and Chairperson | May 04, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | May 08, 2023, 04:24 PM |
| COLES N ANTHONY | CEO and Chairperson | May 04, 2023 | Sale | $31.47 | 50,000 | 1,573,434 | 15,136 | May 08, 2023, 04:24 PM |
| COLES N ANTHONY | CEO and Chairperson | Apr 11, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Apr 13, 2023, 04:48 PM |
| COLES N ANTHONY | CEO and Chairperson | Apr 11, 2023 | Sale | $25.06 | 50,000 | 1,253,130 | 2,704 | Apr 13, 2023, 04:48 PM |
| COLES N ANTHONY | CEO and Chairperson | Mar 02, 2023 | Option Exercise | $3.50 | 47,000 | 164,500 | 49,704 | Mar 06, 2023, 04:15 PM |
| COLES N ANTHONY | CEO and Chairperson | Mar 03, 2023 | Option Exercise | $3.50 | 3,000 | 10,500 | 5,704 | Mar 06, 2023, 04:15 PM |
| COLES N ANTHONY | CEO and Chairperson | Mar 03, 2023 | Sale | $27.19 | 3,000 | 81,570 | 2,704 | Mar 06, 2023, 04:15 PM |
| COLES N ANTHONY | CEO and Chairperson | Mar 02, 2023 | Sale | $27.11 | 47,000 | 1,274,377 | 2,704 | Mar 06, 2023, 04:15 PM |
| COLES N ANTHONY | CEO and Chairperson | Feb 07, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Feb 08, 2023, 08:27 PM |
| COLES N ANTHONY | CEO and Chairperson | Feb 07, 2023 | Sale | $33.13 | 50,000 | 1,656,401 | 10,646 | Feb 08, 2023, 08:27 PM |
| COLES N ANTHONY | CEO and Chairperson | Jan 05, 2023 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Jan 06, 2023, 05:04 PM |
| COLES N ANTHONY | CEO and Chairperson | Jan 05, 2023 | Sale | $29.94 | 50,000 | 1,496,871 | 3,204 | Jan 06, 2023, 05:04 PM |
| COLES N ANTHONY | CEO and Chairperson | Dec 09, 2022 | Option Exercise | $3.50 | 50,000 | 175,000 | 52,704 | Dec 13, 2022, 04:44 PM |
| COLES N ANTHONY | CEO and Chairperson | Dec 09, 2022 | Sale | $26.67 | 50,000 | 1,333,300 | 7,849 | Dec 13, 2022, 04:44 PM |
| Renger John | Chief Scientific Officer | Nov 01, 2022 | Option Exercise | $7.56 | 25,000 | 189,078 | 27,704 | Nov 03, 2022, 04:28 PM |
| Renger John | Chief Scientific Officer | Nov 01, 2022 | Sale | $30.00 | 25,000 | 750,005 | 2,704 | Nov 03, 2022, 04:28 PM |
| Renger John | Chief Scientific Officer | Oct 04, 2022 | Option Exercise | $7.56 | 25,000 | 189,078 | 27,704 | Oct 06, 2022, 04:59 PM |
| Renger John | Chief Scientific Officer | Oct 04, 2022 | Sale | $30.00 | 25,000 | 750,000 | 2,704 | Oct 06, 2022, 04:59 PM |
| PATRICK DEVAL L | Director | Sep 12, 2022 | Option Exercise | $12.62 | 47,705 | 602,037 | 47,705 | Sep 14, 2022, 05:10 PM |
| PATRICK DEVAL L | Director | Sep 12, 2022 | Sale | $30.78 | 47,705 | 1,468,422 | 0 | Sep 14, 2022, 05:10 PM |
| Ceesay Abraham | President | Sep 08, 2022 | Option Exercise | $13.17 | 19,210 | 252,996 | 19,210 | Sep 12, 2022, 04:24 PM |
| Ceesay Abraham | President | Sep 08, 2022 | Sale | $32.50 | 19,210 | 624,325 | 0 | Sep 12, 2022, 04:24 PM |
| Ceesay Abraham | President | Aug 22, 2022 | Option Exercise | $13.17 | 9,605 | 126,498 | 9,605 | Aug 24, 2022, 04:05 PM |
| Ceesay Abraham | President | Aug 22, 2022 | Sale | $32.50 | 9,605 | 312,163 | 0 | Aug 24, 2022, 04:05 PM |
| PERCEPTIVE ADVISORS LLC | Director | Aug 16, 2022 | Buy | $35.00 | 1,425,000 | 49,875,000 | 6,511,727 | Aug 18, 2022, 05:10 PM |
| Ceesay Abraham | President | Aug 15, 2022 | Option Exercise | $13.17 | 9,606 | 126,511 | 9,606 | Aug 17, 2022, 04:15 PM |
| Ceesay Abraham | President | Aug 15, 2022 | Sale | $34.12 | 9,606 | 327,757 | 0 | Aug 17, 2022, 04:15 PM |
| Renger John | Chief Scientific Officer | Aug 10, 2022 | Option Exercise | $6.63 | 55,000 | 364,549 | 57,704 | Aug 12, 2022, 04:15 PM |
| Renger John | Chief Scientific Officer | Aug 10, 2022 | Sale | $40.50 | 55,000 | 2,227,624 | 21,563 | Aug 12, 2022, 04:15 PM |
| Renger John | Chief Scientific Officer | Aug 05, 2022 | Option Exercise | $3.50 | 20,000 | 70,000 | 22,704 | Aug 09, 2022, 09:23 PM |
| Renger John | Chief Scientific Officer | Aug 08, 2022 | Option Exercise | $3.50 | 10,000 | 35,000 | 12,704 | Aug 09, 2022, 09:23 PM |
| Renger John | Chief Scientific Officer | Aug 05, 2022 | Sale | $32.50 | 20,000 | 650,000 | 2,704 | Aug 09, 2022, 09:23 PM |
| Renger John | Chief Scientific Officer | Aug 08, 2022 | Sale | $37.75 | 10,000 | 377,500 | 2,704 | Aug 09, 2022, 09:23 PM |
| Akamine Scott | Chief Legal Officer | Aug 08, 2022 | Option Exercise | $13.17 | 10,000 | 131,700 | 10,000 | Aug 09, 2022, 09:18 PM |
| Akamine Scott | Chief Legal Officer | Aug 08, 2022 | Sale | $40.00 | 10,000 | 400,001 | 0 | Aug 09, 2022, 09:18 PM |
| Ceesay Abraham | President | Aug 05, 2022 | Option Exercise | $13.17 | 38,424 | 506,044 | 38,424 | Aug 09, 2022, 08:59 PM |
| Ceesay Abraham | President | Aug 08, 2022 | Option Exercise | $13.17 | 19,211 | 253,009 | 19,211 | Aug 09, 2022, 08:59 PM |
| Ceesay Abraham | President | Aug 05, 2022 | Sale | $32.50 | 38,424 | 1,248,780 | 0 | Aug 09, 2022, 08:59 PM |
| Ceesay Abraham | President | Aug 08, 2022 | Sale | $38.62 | 19,211 | 742,024 | 9,605 | Aug 09, 2022, 08:59 PM |
| Renger John | Chief Scientific Officer | Jul 20, 2022 | Option Exercise | $3.50 | 25,000 | 87,500 | 27,704 | Jul 22, 2022, 04:15 PM |
| Renger John | Chief Scientific Officer | Jul 20, 2022 | Sale | $30.00 | 25,000 | 750,000 | 2,704 | Jul 22, 2022, 04:15 PM |
| Renger John | Chief Scientific Officer | Jul 05, 2022 | Option Exercise | $3.50 | 25,000 | 87,500 | 27,704 | Jul 07, 2022, 04:06 PM |
| Renger John | Chief Scientific Officer | Jul 06, 2022 | Option Exercise | $3.50 | 1,105 | 3,868 | 3,809 | Jul 07, 2022, 04:06 PM |
| Renger John | Chief Scientific Officer | Jul 05, 2022 | Sale | $30.00 | 25,000 | 750,000 | 2,704 | Jul 07, 2022, 04:06 PM |
| Renger John | Chief Scientific Officer | Jul 06, 2022 | Sale | $32.50 | 1,105 | 35,913 | 2,704 | Jul 07, 2022, 04:06 PM |
| Renger John | Chief Scientific Officer | Apr 13, 2022 | Option Exercise | $3.50 | 45,000 | 157,500 | 46,980 | Apr 15, 2022, 04:19 PM |
| Renger John | Chief Scientific Officer | Apr 13, 2022 | Sale | $34.65 | 45,000 | 1,559,092 | 1,980 | Apr 15, 2022, 04:19 PM |
| Renger John | Chief Scientific Officer | Mar 29, 2022 | Option Exercise | $3.50 | 10,000 | 35,000 | 11,980 | Mar 31, 2022, 04:05 PM |
| Renger John | Chief Scientific Officer | Mar 29, 2022 | Sale | $35.00 | 10,000 | 350,000 | 1,980 | Mar 31, 2022, 04:05 PM |
| Renger John | Chief Scientific Officer | Mar 18, 2022 | Option Exercise | $3.50 | 20,000 | 70,000 | 21,980 | Mar 18, 2022, 07:56 PM |
| Renger John | Chief Scientific Officer | Mar 16, 2022 | Option Exercise | $3.50 | 25,000 | 87,500 | 26,980 | Mar 18, 2022, 07:56 PM |
| Renger John | Chief Scientific Officer | Mar 16, 2022 | Sale | $30.00 | 25,000 | 750,005 | 1,980 | Mar 18, 2022, 07:56 PM |
| Renger John | Chief Scientific Officer | Mar 18, 2022 | Sale | $32.50 | 20,000 | 650,004 | 1,980 | Mar 18, 2022, 07:56 PM |
| Renger John | Chief Scientific Officer | Mar 09, 2022 | Option Exercise | $3.50 | 30,000 | 105,000 | 31,980 | Mar 11, 2022, 04:08 PM |
| Renger John | Chief Scientific Officer | Mar 09, 2022 | Sale | $33.33 | 30,000 | 1,000,000 | 11,980 | Mar 11, 2022, 04:08 PM |
| Renger John | Chief Scientific Officer | Mar 02, 2022 | Option Exercise | $3.50 | 25,000 | 87,500 | 26,980 | Mar 04, 2022, 04:12 PM |
| Renger John | Chief Scientific Officer | Mar 02, 2022 | Sale | $30.00 | 25,000 | 750,000 | 1,980 | Mar 04, 2022, 04:12 PM |
| Renger John | Chief Scientific Officer | Feb 09, 2022 | Option Exercise | $3.50 | 25,000 | 87,500 | 26,980 | Feb 11, 2022, 06:46 PM |
| Renger John | Chief Scientific Officer | Feb 09, 2022 | Sale | $30.00 | 25,000 | 750,000 | 1,980 | Feb 11, 2022, 06:46 PM |
| Renger John | Chief Scientific Officer | Dec 27, 2021 | Option Exercise | $3.50 | 4,127 | 14,445 | 6,107 | Dec 28, 2021, 04:31 PM |
| Renger John | Chief Scientific Officer | Dec 23, 2021 | Option Exercise | $3.50 | 5,873 | 20,556 | 7,853 | Dec 28, 2021, 04:31 PM |
| Renger John | Chief Scientific Officer | Dec 27, 2021 | Sale | $35.00 | 4,127 | 144,445 | 1,980 | Dec 28, 2021, 04:31 PM |
| Renger John | Chief Scientific Officer | Dec 23, 2021 | Sale | $35.00 | 5,873 | 205,582 | 1,980 | Dec 28, 2021, 04:31 PM |
| Renger John | Chief Scientific Officer | Dec 21, 2021 | Option Exercise | $3.50 | 7,300 | 25,550 | 9,280 | Dec 23, 2021, 05:14 PM |
| Renger John | Chief Scientific Officer | Dec 21, 2021 | Sale | $32.50 | 7,300 | 237,250 | 1,980 | Dec 23, 2021, 05:14 PM |
| Renger John | Chief Scientific Officer | Dec 15, 2021 | Option Exercise | $3.50 | 25,000 | 87,500 | 26,980 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Dec 17, 2021 | Option Exercise | $3.50 | 7,122 | 24,927 | 9,102 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Dec 16, 2021 | Option Exercise | $3.50 | 5,578 | 19,523 | 7,558 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Dec 15, 2021 | Sale | $30.02 | 25,000 | 750,448 | 1,980 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Dec 17, 2021 | Sale | $32.50 | 7,122 | 231,465 | 1,980 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Dec 16, 2021 | Sale | $32.50 | 5,578 | 181,285 | 1,980 | Dec 17, 2021, 08:27 PM |
| Renger John | Chief Scientific Officer | Nov 10, 2021 | Option Exercise | $3.50 | 55,000 | 192,500 | 55,000 | Nov 15, 2021, 04:18 PM |
| Renger John | Chief Scientific Officer | Nov 10, 2021 | Sale | $39.86 | 55,000 | 2,192,187 | 31,368 | Nov 15, 2021, 04:18 PM |
| PERCEPTIVE ADVISORS LLC | Director | Aug 26, 2021 | Buy | $30.23 | 68,047 | 2,057,061 | 5,086,727 | Aug 31, 2021, 02:15 PM |
| PERCEPTIVE ADVISORS LLC | Director | Aug 24, 2021 | Buy | $27.73 | 69,761 | 1,934,472 | 4,957,293 | Aug 25, 2021, 07:14 PM |
| PERCEPTIVE ADVISORS LLC | Director | Aug 23, 2021 | Buy | $25.78 | 44,437 | 1,145,586 | 4,887,532 | Aug 25, 2021, 07:14 PM |
| PERCEPTIVE ADVISORS LLC | Director | Aug 25, 2021 | Buy | $28.57 | 61,387 | 1,753,827 | 5,018,680 | Aug 25, 2021, 07:14 PM |
| PERCEPTIVE ADVISORS LLC | Director | Jul 07, 2021 | Buy | $25.00 | 200,000 | 5,000,000 | 4,843,095 | Jul 09, 2021, 06:39 PM |
| Sulzberger Gabrielle | Director | Jun 17, 2021 | Buy | $13.06 | 21,084 | 275,357 | 35,354 | Jun 22, 2021, 06:31 PM |
| MISHAN ORLY | Chief Business Officer | Jan 26, 2021 | Option Exercise | $3.50 | 38,450 | 134,575 | 38,450 | Jan 28, 2021, 07:35 PM |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | Nov 09, 2020 | Buy | $10.30 | 332,293 | 3,422,618 | 60,632,356 | Nov 12, 2020, 05:54 PM |
| Koppel Adam | Director | Nov 09, 2020 | Buy | $10.30 | 332,293 | 3,422,618 | 60,632,356 | Nov 12, 2020, 05:54 PM |
| Gordon Christopher R | Director | Nov 09, 2020 | Buy | $10.30 | 332,293 | 3,422,618 | 60,632,356 | Nov 12, 2020, 05:51 PM |
| PERCEPTIVE ADVISORS LLC | Director | Oct 27, 2020 | Buy | $10.00 | 3,000,000 | 30,000,000 | 3,157,295 | Oct 29, 2020, 08:00 PM |
| Koppel Adam | Director | Oct 27, 2020 | Buy | $10.00 | 10,000,000 | 100,000,000 | 60,300,063 | Oct 29, 2020, 08:00 PM |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | Oct 27, 2020 | Buy | $10.00 | 10,000,000 | 100,000,000 | 60,300,063 | Oct 29, 2020, 08:00 PM |
| Gordon Christopher R | Director | Oct 27, 2020 | Buy | $10.00 | 10,000,000 | 100,000,000 | 60,300,063 | Oct 29, 2020, 08:00 PM |
| PFIZER INC | 10% Owner | Oct 27, 2020 | Buy | $10.00 | 1,200,000 | 12,000,000 | 27,349,211 | Oct 29, 2020, 05:44 PM |
| PERCEPTIVE ADVISORS LLC | Director | Oct 21, 2020 | Buy | $10.09 | 43,195 | 435,838 | 157,295 | Oct 22, 2020, 08:34 PM |
| PERCEPTIVE ADVISORS LLC | Director | Oct 20, 2020 | Buy | $10.00 | 114,100 | 1,141,000 | 114,100 | Oct 22, 2020, 08:34 PM |
| ARYA Sciences Holdings II | 10% Owner | Jun 09, 2020 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Jun 09, 2020, 08:25 PM |
| Stone Adam Leo | Chief Executive Officer | Jun 09, 2020 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Jun 09, 2020, 08:25 PM |
| ALTMAN MICHAEL SETH | Chief Financial Officer | Jun 09, 2020 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Jun 09, 2020, 08:23 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| COLES N ANTHONY | Director | 04/01/2024 | 175,000 |
| COLES N ANTHONY | Director | 04/01/2024 | 2,116,640 |
| COLES N ANTHONY | Director | 03/04/2024 | 175,000 |
| COLES N ANTHONY | Director | 03/04/2024 | 2,050,550 |
| COLES N ANTHONY | Director | 02/29/2024 | 175,000 |
| COLES N ANTHONY | Director | 02/29/2024 | 2,057,890 |
| Renger John | Chief Scientific Officer | 02/07/2024 | 89,777 |
| COLES N ANTHONY | Director | 02/07/2024 | 104,110 |
| Tregoning Kathleen | See Remarks | 12/26/2023 | 31,658 |
| Sanchez Ramiro | Chief Medical Officer | 12/26/2023 | 35,000 |
| Sanchez Ramiro | Chief Medical Officer | 12/26/2023 | 424,700 |
| DiPietro Kenneth | Chief Human Resources Officer | 12/22/2023 | 28,000 |
| DiPietro Kenneth | Chief Human Resources Officer | 12/22/2023 | 331,608 |
| Bodenrader Mark | See Remarks | 12/20/2023 | 326,788 |
| DiPietro Kenneth | Chief Human Resources Officer | 12/20/2023 | 259,144 |
| Akamine Scott | Chief Legal Officer | 12/20/2023 | 292,945 |
| Sanchez Ramiro | Chief Medical Officer | 12/20/2023 | 420,528 |
| ALTSCHULLER Susan | Chief Financial Officer | 12/20/2023 | 571,972 |
| Tregoning Kathleen | See Remarks | 12/20/2023 | 260,469 |
| Sanchez Ramiro | Chief Medical Officer | 12/15/2023 | 74,100 |
| Sanchez Ramiro | Chief Medical Officer | 12/15/2023 | 310,393 |
| Sanchez Ramiro | Chief Medical Officer | 12/07/2023 | 35,000 |
| Sanchez Ramiro | Chief Medical Officer | 12/07/2023 | 413,700 |
| Akamine Scott | Chief Legal Officer | 12/07/2023 | 131,700 |
| Akamine Scott | Chief Legal Officer | 12/05/2023 | 98,775 |
| Akamine Scott | Chief Legal Officer | 12/07/2023 | 413,700 |
| Akamine Scott | Chief Legal Officer | 12/05/2023 | 262,500 |
| COLES N ANTHONY | Director | 11/14/2023 | 79,884 |
| COLES N ANTHONY | Director | 11/14/2023 | 573,455 |
| COLES N ANTHONY | Director | 11/08/2023 | 350 |
| COLES N ANTHONY | Director | 11/07/2023 | 94,766 |
| COLES N ANTHONY | Director | 11/08/2023 | 2,516 |
| COLES N ANTHONY | Director | 11/07/2023 | 677,555 |
| COLES N ANTHONY | Director | 11/02/2023 | 135,097 |
| COLES N ANTHONY | Director | 11/03/2023 | 214,904 |
| COLES N ANTHONY | Director | 11/02/2023 | 972,239 |
| COLES N ANTHONY | Director | 11/03/2023 | 1,561,458 |
| PATRICK DEVAL L | Director | 11/01/2023 | 380,241 |
| PATRICK DEVAL L | Director | 11/01/2023 | 753,250 |
| Gordon Christopher R | Director | 10/16/2023 | 124,999,983 |
| Koppel Adam | Director | 10/16/2023 | 124,999,983 |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | 10/16/2023 | 124,999,983 |
| PERCEPTIVE ADVISORS LLC | Director | 10/16/2023 | 19,999,990 |
| COLES N ANTHONY | Director | 09/07/2023 | 175,000 |
| COLES N ANTHONY | Director | 09/07/2023 | 1,203,415 |
| Renaud Ronald C JR | President & CEO | 08/03/2023 | 2,008,811 |
| Burgess Paul D. | See Remarks | 08/04/2023 | 501,794 |
| COLES N ANTHONY | Director | 07/11/2023 | 175,000 |
| COLES N ANTHONY | Director | 07/11/2023 | 1,501,340 |
| DEKKERS MARIJN E | Director | 06/15/2023 | 6,886,000 |
| COLES N ANTHONY | CEO and Chairperson | 06/01/2023 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 06/01/2023 | 1,630,070 |
| Bodenrader Mark | See Remarks | 06/02/2023 | 62,440 |
| COLES N ANTHONY | CEO and Chairperson | 05/04/2023 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 05/04/2023 | 1,573,434 |
| COLES N ANTHONY | CEO and Chairperson | 04/11/2023 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 04/11/2023 | 1,253,130 |
| COLES N ANTHONY | CEO and Chairperson | 03/02/2023 | 164,500 |
| COLES N ANTHONY | CEO and Chairperson | 03/03/2023 | 10,500 |
| COLES N ANTHONY | CEO and Chairperson | 03/03/2023 | 81,570 |
| COLES N ANTHONY | CEO and Chairperson | 03/02/2023 | 1,274,377 |
| COLES N ANTHONY | CEO and Chairperson | 02/07/2023 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 02/07/2023 | 1,656,401 |
| COLES N ANTHONY | CEO and Chairperson | 01/05/2023 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 01/05/2023 | 1,496,871 |
| COLES N ANTHONY | CEO and Chairperson | 12/09/2022 | 175,000 |
| COLES N ANTHONY | CEO and Chairperson | 12/09/2022 | 1,333,300 |
| Renger John | Chief Scientific Officer | 11/01/2022 | 189,078 |
| Renger John | Chief Scientific Officer | 11/01/2022 | 750,005 |
| Renger John | Chief Scientific Officer | 10/04/2022 | 189,078 |
| Renger John | Chief Scientific Officer | 10/04/2022 | 750,000 |
| PATRICK DEVAL L | Director | 09/12/2022 | 602,037 |
| PATRICK DEVAL L | Director | 09/12/2022 | 1,468,422 |
| Ceesay Abraham | President | 09/08/2022 | 252,996 |
| Ceesay Abraham | President | 09/08/2022 | 624,325 |
| Ceesay Abraham | President | 08/22/2022 | 126,498 |
| Ceesay Abraham | President | 08/22/2022 | 312,163 |
| PERCEPTIVE ADVISORS LLC | Director | 08/16/2022 | 49,875,000 |
| Ceesay Abraham | President | 08/15/2022 | 126,511 |
| Ceesay Abraham | President | 08/15/2022 | 327,757 |
| Renger John | Chief Scientific Officer | 08/10/2022 | 364,549 |
| Renger John | Chief Scientific Officer | 08/10/2022 | 2,227,624 |
| Renger John | Chief Scientific Officer | 08/05/2022 | 70,000 |
| Renger John | Chief Scientific Officer | 08/08/2022 | 35,000 |
| Renger John | Chief Scientific Officer | 08/05/2022 | 650,000 |
| Renger John | Chief Scientific Officer | 08/08/2022 | 377,500 |
| Akamine Scott | Chief Legal Officer | 08/08/2022 | 131,700 |
| Akamine Scott | Chief Legal Officer | 08/08/2022 | 400,001 |
| Ceesay Abraham | President | 08/05/2022 | 506,044 |
| Ceesay Abraham | President | 08/08/2022 | 253,009 |
| Ceesay Abraham | President | 08/05/2022 | 1,248,780 |
| Ceesay Abraham | President | 08/08/2022 | 742,024 |
| Renger John | Chief Scientific Officer | 07/20/2022 | 87,500 |
| Renger John | Chief Scientific Officer | 07/20/2022 | 750,000 |
| Renger John | Chief Scientific Officer | 07/05/2022 | 87,500 |
| Renger John | Chief Scientific Officer | 07/06/2022 | 3,868 |
| Renger John | Chief Scientific Officer | 07/05/2022 | 750,000 |
| Renger John | Chief Scientific Officer | 07/06/2022 | 35,913 |
| Renger John | Chief Scientific Officer | 04/13/2022 | 157,500 |
| Renger John | Chief Scientific Officer | 04/13/2022 | 1,559,092 |
| Renger John | Chief Scientific Officer | 03/29/2022 | 35,000 |
| Renger John | Chief Scientific Officer | 03/29/2022 | 350,000 |
| Renger John | Chief Scientific Officer | 03/18/2022 | 70,000 |
| Renger John | Chief Scientific Officer | 03/16/2022 | 87,500 |
| Renger John | Chief Scientific Officer | 03/16/2022 | 750,005 |
| Renger John | Chief Scientific Officer | 03/18/2022 | 650,004 |
| Renger John | Chief Scientific Officer | 03/09/2022 | 105,000 |
| Renger John | Chief Scientific Officer | 03/09/2022 | 1,000,000 |
| Renger John | Chief Scientific Officer | 03/02/2022 | 87,500 |
| Renger John | Chief Scientific Officer | 03/02/2022 | 750,000 |
| Renger John | Chief Scientific Officer | 02/09/2022 | 87,500 |
| Renger John | Chief Scientific Officer | 02/09/2022 | 750,000 |
| Renger John | Chief Scientific Officer | 12/27/2021 | 14,445 |
| Renger John | Chief Scientific Officer | 12/23/2021 | 20,556 |
| Renger John | Chief Scientific Officer | 12/27/2021 | 144,445 |
| Renger John | Chief Scientific Officer | 12/23/2021 | 205,582 |
| Renger John | Chief Scientific Officer | 12/21/2021 | 25,550 |
| Renger John | Chief Scientific Officer | 12/21/2021 | 237,250 |
| Renger John | Chief Scientific Officer | 12/15/2021 | 87,500 |
| Renger John | Chief Scientific Officer | 12/17/2021 | 24,927 |
| Renger John | Chief Scientific Officer | 12/16/2021 | 19,523 |
| Renger John | Chief Scientific Officer | 12/15/2021 | 750,448 |
| Renger John | Chief Scientific Officer | 12/17/2021 | 231,465 |
| Renger John | Chief Scientific Officer | 12/16/2021 | 181,285 |
| Renger John | Chief Scientific Officer | 11/10/2021 | 192,500 |
| Renger John | Chief Scientific Officer | 11/10/2021 | 2,192,187 |
| PERCEPTIVE ADVISORS LLC | Director | 08/26/2021 | 2,057,061 |
| PERCEPTIVE ADVISORS LLC | Director | 08/24/2021 | 1,934,472 |
| PERCEPTIVE ADVISORS LLC | Director | 08/23/2021 | 1,145,586 |
| PERCEPTIVE ADVISORS LLC | Director | 08/25/2021 | 1,753,827 |
| PERCEPTIVE ADVISORS LLC | Director | 07/07/2021 | 5,000,000 |
| Sulzberger Gabrielle | Director | 06/17/2021 | 275,357 |
| MISHAN ORLY | Chief Business Officer | 01/26/2021 | 134,575 |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | 11/09/2020 | 3,422,618 |
| Koppel Adam | Director | 11/09/2020 | 3,422,618 |
| Gordon Christopher R | Director | 11/09/2020 | 3,422,618 |
| PERCEPTIVE ADVISORS LLC | Director | 10/27/2020 | 30,000,000 |
| Koppel Adam | Director | 10/27/2020 | 100,000,000 |
| BAIN CAPITAL INVESTORS LLC | 10% Owner | 10/27/2020 | 100,000,000 |
| Gordon Christopher R | Director | 10/27/2020 | 100,000,000 |
| PFIZER INC | 10% Owner | 10/27/2020 | 12,000,000 |
| PERCEPTIVE ADVISORS LLC | Director | 10/21/2020 | 435,838 |
| PERCEPTIVE ADVISORS LLC | Director | 10/20/2020 | 1,141,000 |
| ARYA Sciences Holdings II | 10% Owner | 06/09/2020 | 4,990,000 |
| Stone Adam Leo | Chief Executive Officer | 06/09/2020 | 4,990,000 |
| ALTMAN MICHAEL SETH | Chief Financial Officer | 06/09/2020 | 4,990,000 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR
STOCK BUYBACKS FOR
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
12.39%
1Q
06/30/2023
12.71%
2Q
03/31/2023
13.00%
3Q
12/31/2022
13.16%
4Q
09/30/2022
16.23%
5Q
06/30/2022
19.37%
6Q
03/31/2022
19.62%
7Q
12/31/2021
20.10%
8Q
09/30/2021
22.91%
9Q
06/30/2021
38.86%
10Q
03/31/2021
39.14%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...